The Relationship between Endothelial Nitric Oxide Synthase Gene Polymorphism (G894T) and Isole Coronary Artery Ectasia  by İçli, Atilla et al.
Coronary Care Unit Patient Proﬁle and in-Hospital Mortality
Group 1
(n¼2041)
Group 2
(n¼1181)
Age average (year) 59 63
Female (%) 24 28
Acute coronary syndrome (%) 79 72
ST elevated ACS (All of ACS) (%) 59 40
Non ST elevated ACS (All of ACS) (%) 41 60
Rhythm and conduction abnormalities (%) 9 13
Heart failure and pulmonary edema (%) 7 9
Cardiogenic shock and cardiopulmonary arrest (%) 1,9 1,3
Others (Valvular heart diseases, aort dissection,
pericardial diseases, syncope, pulmonary diseases,
acute pulmonary embolism, etc) (%)
3 4,7
Hospital mortality (%) 9 4,4
Hospital mortality of ACS (%) 6 4,3
Hospital mortality of ST elevated ACS (%) 6 5
Hospital mortality of non ST elevated ACS (%) 5 4,1
Hospital mortality of rhythm and conduction
abnormalities (%)
11 9
Hospital mortality of heart failure and pulmonary
edema (%)
11 8
Hospital mortality of cardiogenic shock and
cardiopulmonary arrest (%)
65 47
Endothelial nitric oxide synthase gene (G894T) polymorphisms genotype and
allel frequencies
CAE
(n:65)
%
Controls
(n:65)
% Pn: n:
GG genotype 22 33.8 41 63.1 0.001
GT genotype 38 58.5 22 33.8 0.005
TT genotype 5 7.7 2 3.1 0.244
GT + TT genotypes
(Dominant genetic
model)
43 66.2 24 36.9 0.001
T allel 48 36.9 26 20 0.004
P
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Background: Coronary artery ectasia (CAE) is deﬁned as local or generalized
aneurysmal dilatation of the coronary arteries. Although the etiology of CAE has not
been identiﬁed completely, the most frequent cause is coronary atherosclerosis. It is
known that an expansive remodelling occurs in atherosclerotic coronary arteries due to
plague rupture and increased plague burden particularly in early stages. Endothelial
nitric oxide synthase (eNOS) has important role in modulating smooth muscle tonus
and vessel diameter. Polymorphism of the eNOS (G894T) gene has been associated
with altered function of this gene and its products. Experimental and clinical data
suggesting that; in the absence of eNOS, endothelial functions and luminal remodeling
is impaired, the vessel wall thickness is increased, atherosclerosis accelerated and got
complicated.In this study, we investigated the eNOS gene polymorphism (G894T) in
patients with CAE.
Methods: Sixty ﬁve patients with isolated CAE (mean age 537 years) and 65
controls with normal coronary angiograms (mean age 517 years) were included in
the study. eNOS G894T gene polymorphisms were analysed by polymerase chain
reaction and restriction fragment length polymorphism. For each polymorphic posi-
tion, one of three possible patterns may be obtained: Normal (GG) genotype,
heterozygous (GT), or homozygous (TT) mutant genotype. Demographic character-
istics and major risk factors for atherosclerosis were evaluated in the study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. Genotype distribution of CAE and control groups shown in the table. The
frequency of the GT heterozygous genotype was signiﬁcantly higher in CAE group
than controls (38 (%58,5) vs 22 (%33.8), p¼0.005). Between the two groups were
compared according to the dominant genetic model (GT+TT vs. GG), The number of
patients carrying at least one T mutant allele (GT+TT) was signiﬁcantly higher in
CAE than controls (43 (%66.2) vs 24 (%36.9), p¼0.001). With respect to allelic
distribution (G vs T, additive model), the frequency of the T mutant allele was
signiﬁcantly higher in CAE patients. (48 (%36.9) vs 26 (%20), p¼0.004).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-315
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Background: The association of epicardial adipose tissue (EAT) with coronary artery
disease has been shown in previous studies. Furthermore the relationship between
EAT and acute coronary syndrome was studied recently. Herein, we investigated the
relationship between EAT thickness and the Thrombolysis in Myocardial Infarction
(TIMI) risk score for non-ST elevation myocardial infarction (NSTEMI) and unstable
angina pectoris (USAP).
Methods: A total of 144 patients with NSTEMI/USAP were included. Study pop-
ulation was divided into two sub-groups according to TIMI risk scores as group I: 4
(n¼86) and group II: >4 (n¼58). Stepwise multivariable logistic regression analysis
was used to assess the independent association of clinical parameters with TIMI risk
score.
Results: EAT thickness was higher in Group II compared to Group I (8.22.1 vs
6.22.2, p<0.001). Also patients in Group II showed higher rate of multivessel
disease and Gensini score (p<0.001). In univariate linear regression analysis, EAT
was positively correlated with TIMI risk score and Gensini score. Multivariate
regression analysis showed that EAT thickness (OR: 1.56, 95% CI: 1.17-2.08,
p¼0.003), LVEF (OR: 0.93, 95% CI: 0.85-0.98, p¼0.03) and Gensini score (OR:
1.36, 95% CI: 1.24-1.98, p¼0.002) were independently associated with higher TIMI
risk score.
Conclusıon: In conclusion, EAT thickness is independently associated with TIMI risk
score and may be an emerging risk factor for adverse events in NSTEMI/USAP.ERS C207
